First Time Loading...
C

Clarus Therapeutics Holdings Inc
NASDAQ:CRXT

Watchlist Manager
Clarus Therapeutics Holdings Inc
NASDAQ:CRXT
Watchlist
Price: 0.021 USD -19.54% Market Closed
Updated: May 29, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Cash Flow Statement

-60.8m
-39%
Operating Cash Flow
Mar 31, 2022 -60.8m
Dec 31, 2021 -43.8m
Sep 30, 2021 -40.4m
Jun 30, 2021 -63.5m
-35k
-40%
Investing Cash Flow
Mar 31, 2022 -35k
Dec 31, 2021 -25k
Sep 30, 2021 -21k
Jun 30, 2021 -83k
63m
+0%
Financing Cash Flow
Mar 31, 2022 63m
Dec 31, 2021 63m
Sep 30, 2021 49.2m
Jun 30, 2021 72.2m

Cash Flow Statement
Clarus Therapeutics Holdings Inc

Rotate your device to view
Cash Flow Statement
Currency: USD
Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022
Operating Cash Flow
Net Income
15
(29)
(36)
(41)
(66)
Depreciation & Amortization
0
0
0
0
0
Other Non-Cash Items
(65)
(44)
(1)
4
11
Cash Interest Paid
3
3
3
0
6
Change in Working Capital
8
9
(3)
(7)
(6)
Cash from Operating Activities
(42)
N/A
(64)
-52%
(40)
+36%
(44)
-8%
(61)
-39%
Investing Cash Flow
Capital Expenditures
0
(0)
(0)
(0)
(0)
Cash from Investing Activities
0
N/A
(0)
N/A
(0)
+75%
(0)
-19%
(0)
-40%
Financing Cash Flow
Net Issuance of Common Stock
0
0
0
14
0
Net Issuance of Debt
0
76
32
32
32
Other
(4)
(4)
17
17
0
Cash from Financing Activities
47
N/A
72
+53%
49
-32%
63
+28%
63
+0%
Change in Cash
Net Change in Cash
5
N/A
9
+62%
9
+2%
19
+118%
2
-89%
Free Cash Flow
Free Cash Flow
(42)
N/A
(64)
-52%
(40)
+36%
(44)
-8%
(61)
-39%

See Also

Summary
CRXT intrinsic value, competitors valuation, and company profile.
DCF Valuation
CRXT stock valuation using Discount Cash Flow valuation method.
Relative Valuation
CRXT stock valuation using valuation multiples.
Wall Street Estimates
CRXT price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
CRXT stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 141,600+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.